Article
Predictive Performance and Clinical Application of COV50, A Urinary Proteomic Biomarker in Early COVID-19 Infection: A Cohort Study
2022-01-25
Abstract excerpt
Background: The SARS‑CoV‑2 pandemic remains a worldwide challenge. The CRIT‑Cov‑U pilot study generated a urinary proteomic biomarker consisting of 50 peptides (COV50), which predicted death and disease progression. Following the interim analysis demanded by the German government, the full dataset was analysed to consolidate findings and propose clinical applications. <br><br>Methods: In eight European countries...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56124ffd-7de5-521f-8eff-7fb14ed04e27
- DOI
- 10.2139/ssrn.4006139
